← All FR Documents
Notice

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE25-025, Rigorous Evaluation of Community- and Societal-Level Primary Prevention Approaches To Prevent Adverse Childhood Experiences (ACEs): Expanding the Best Available Evidence; Amended Notice of Closed Meeting

Notice.

📖 Research Context From Federal Register API

Key Dates
Citation: 90 FR 4744
February 25, 2025.
Public Participation

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, Centers for Disease Control and Prevention. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Notice.

When does it take effect?

February 25, 2025.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-00856
FR Citation90 FR 4744
TypeNotice
PublishedJan 16, 2025
Effective Date-
RIN-
Docket ID-
Pages4744–4744 (1 pages)
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (357 words · ~2 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>Centers for Disease Control and Prevention</SUBAGY> <SUBJECT>Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE25-025, Rigorous Evaluation of Community- and Societal-Level Primary Prevention Approaches To Prevent Adverse Childhood Experiences (ACEs): Expanding the Best Available Evidence; Amended Notice of Closed Meeting</SUBJECT> <HD SOURCE="HED">AGENCY:</HD> Centers for Disease Control and Prevention, Department of Health and Human Services. <HD SOURCE="HED">ACTION:</HD> Notice. <FURINF> <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD> Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341. Telephone: (770) 488-1504; Email: <E T="03">AWilkes@cdc.gov.</E> </FURINF> <SUPLINF> <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD> Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE25-025, Rigorous Evaluation of Community- and Societal-Level Primary Prevention Approaches To Prevent Adverse Childhood Experiences (ACEs): Expanding the Best Available Evidence; February 25-26, 2025, 10 a.m.-5 p.m., EST, web conference, in the original <E T="04">Federal Register</E> notice. The meeting notice was published in the <E T="04">Federal Register</E> on November 27, 2024, 89 FR 93606 and 93607. This meeting notice is being amended to change the meeting dates from a two-day meeting to a one-day meeting. The notice should read as follows: <E T="03">Name of Committee:</E> Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE25-025, Rigorous Evaluation of Community- and Societal-Level Primary Prevention Approaches To Prevent Adverse Childhood Experiences (ACEs): Expanding the Best Available Evidence. <E T="03">Date:</E> February 25, 2025. <E T="03">Time:</E> 10 a.m.-5 p.m., EST. The meeting is closed to the public. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign <E T="04">Federal Register</E> notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. <SIG> <NAME>Kalwant Smagh,</NAME> Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. </SIG> </SUPLINF> <FRDOC>[FR Doc. 2025-00856 Filed 1-15-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison.